Geng et al. in their 2022 review explored the links between gut microbiota and obesity-related diseases, such as diabetes and cardiovascular disease, highlighting the therapeutic potential of prebiotics and probiotics in reducing systemic inflammation and improving insulin sensitivity. Here, INS is linked to diabetes mellitus.